|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 21.51 USD | +0.75% |
|
+5.54% | +70.71% |
| 10-28 | US estrogen supply crunch widens as women seek alternatives to scarce patches | RE |
| 09-23 | Amneal Pharmaceuticals' Biosimilars, Specialty Growth Reshape Earnings Profile, Oppenheimer Says | MT |
| Market Cap | 7.49B 6.71B 6.17B 5.59B 10.45B 711B 10.65B 73.6B 29.55B 374B 28.12B 27.52B 1,180B | P/E 2026 * |
44.2x | P/E 2027 * | 32.9x |
|---|---|---|---|---|---|
| Enterprise Value | 9.93B 8.89B 8.18B 7.41B 13.85B 942B 14.11B 97.51B 39.15B 496B 37.25B 36.46B 1,563B | EV / Sales 2026 * |
3.14x | EV / Sales 2027 * | 2.78x |
| Free-Float |
44.36% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMRX | Delayed | |
CBOE
| AMRX | Real-time | |
|
Tradegate
| 2DT | Real-time | |
|
Deutsche Boerse AG
| 2DT | Delayed | |
|
Börse Stuttgart
| 2DT | Delayed | |
|
Boerse Muenchen
| 2DT | Real-time |
Last Transcript: Amneal Pharmaceuticals, Inc.
| 1 day | +0.75% | ||
| 1 week | +5.54% | ||
| 1 month | +6.80% | ||
| 3 months | +17.41% | ||
| 6 months | +67.13% | ||
| Current year | +70.71% |
| 1 week | 20.54 |  | 21.68 |
| 1 month | 18.78 | | 21.68 |
| Current year | 11.71 | | 21.68 |
| 1 year | 10.68 | | 21.68 |
| 3 years | 3.91 | | 21.68 |
| 5 years | 1.24 | | 21.68 |
| 10 years | 1.24 | | 24.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Chirag K. Patel
CEO | Chief Executive Officer | 59 | 31/07/2019 |
Chintu Patel
CEO | Chief Executive Officer | 54 | 31/07/2019 |
| Director of Finance/CFO | 58 | 06/11/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Deborah Autor
BRD | Director/Board Member | 59 | 06/11/2023 |
J. Buchi
BRD | Director/Board Member | 71 | 06/11/2023 |
Jeffrey George
BRD | Director/Board Member | 52 | 06/11/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/09/26 | Don | Director | -20,445 | 0.0064% | ||
| 11/09/26 | Exercice | Director | 40,890 | 0.0128% | ||
| 01/09/26 | Don | Executive/Senior Manager | -80,000 | 0.0251% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.75% | +5.54% | +98.80% | +455.81% | 7.49B | |
| +3.19% | +11.31% | +64.28% | +155.91% | 1,263B | |
| -0.73% | +3.56% | +44.65% | +84.17% | 658B | |
| +1.41% | +3.24% | +35.25% | +108.88% | 521B | |
| +0.42% | +3.20% | +55.81% | +72.50% | 391B | |
| +2.18% | +2.93% | +73.90% | +45.59% | 369B | |
| +1.12% | +4.52% | +34.76% | +58.24% | 307B | |
| +6.96% | +8.86% | +11.95% | +36.20% | 290B | |
| +1.15% | +6.09% | +56.15% | +82.25% | 252B | |
| +3.06% | +9.38% | +42.48% | +117.32% | 212B | |
| Average | +1.95% | +5.86% | +51.80% | +121.69% | 426.94B | |
| Weighted average by Cap. | +2.00% | +6.60% | +50.59% | +101.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.16B 2.83B 2.6B 2.36B 4.41B 300B 4.49B 31.06B 12.47B 158B 11.87B 11.61B 498B | 3.46B 3.1B 2.85B 2.58B 4.82B 328B 4.91B 33.97B 13.64B 173B 12.98B 12.7B 545B |
| Net income | 165M 148M 136M 123M 231M 15.69B 235M 1.62B 652M 8.25B 620M 607M 26.02B | 227M 203M 187M 169M 316M 21.52B 322M 2.23B 894M 11.32B 851M 832M 35.7B |
| Net Debt | 2.43B 2.18B 2.01B 1.82B 3.4B 231B 3.46B 23.91B 9.6B 122B 9.14B 8.94B 383B | 2.13B 1.91B 1.76B 1.59B 2.97B 202B 3.03B 20.94B 8.41B 106B 8B 7.83B 336B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$21.51 | +0.75% | 2,765,562 |
| 29/10/26 | US$21.35 | +0.99% | 4,400,169 |
| 28/10/26 | US$21.14 | -1.40% | 3,309,720 |
| 27/10/26 | US$21.44 | +2.00% | 2,888,253 |
| 26/10/26 | US$21.02 | +3.14% | 4,945,331 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMRX Stock
Select your edition
All financial news and data tailored to specific country editions
